The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin (Q73692052)
scientific article published on 01 January 1997
Language:
(P31) (Q13442814)
(P304) 561-564
(P407) (Q1860)
(P433) 4-5
(P478) 104
(P577) Wednesday, January 1, 1997
Wednesday, January 1, 1997
(P921) (Q41112)
(P953) http://link.springer.com/content/pdf/10.1007/BF01277672.pdf
http://link.springer.com/article/10.1007/BF01277672/fulltext.html
http://link.springer.com/content/pdf/10.1007/BF01277672
(P1433) (Q15750921)
(P1476) "The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication)" (language: en)
"The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin" (language: en)
(P2093) P. Martin
N. Waters
A. Carlsson
M. L. Carlsson
(P2860) (Q28303964)
(Q43513577)
(Q28282022)
(Q37783090)
(Q37885973)
(Q36798643)
(Q71370084)
(Q24629716)
(Q72659567)
(Q72232549)
(Q41195661)
(Q35942133)
(Q71962696)
(Q1943386)
(Q1127934)
(Q1127934)
other details
description scientific article published on 01 January 1997

External Links